For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE

For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE

The Path to an Alzheimer’s Drug

When Adam Raikes, PhD, meets someone new, he’s inevitably asked about his job. He may tell them he’s an assistant scientific investigator at the University of Arizona Health Sciences Center for Innovation in Brain Science (CIBS). Pushed for more details, he might say he processes, reconstructs and analyzes raw data from brain MRIs. If they respond with a blank stare, he’ll take out his smartphone and show them an image: wisps of multicolored fibers arrayed in the shape of a brain.

“That’s what I do,” he tells them. “I make this picture.”

In Dr. Raikes’ case, a picture really is worth a thousand words. Read more…

Leave a Reply

Your email address will not be published.

The Center for Innovation in Brain Science (CIBS) at the University of Arizona is addressing the challenge that, in the 21st century, there is not a single cure for a single neurodegenerative disease and is focused on four age-associated neurodegenerative diseases: Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS.

© 2021 Center for Innovation Brain Science. University of Arizona Health Sciences.